Rubinstein-Taybi syndrome (RSTS) is a complex autosomal-dominant disease characterized by mental and growth retardation and skeletal abnormalities. A majority of the individuals diagnosed with RSTS carry heterozygous mutation in the gene CREBBP, but a small percentage of cases are caused by mutations in EP300. To investigate the contribution of p300 to RSTS pathoetiology, we carried out a comprehensive and multidisciplinary characterization of p300 +/− mice. These mice exhibited facial abnormalities and impaired growth, two traits associated to RSTS in humans. We also observed abnormal gait, reduced swimming speed, enhanced anxiety in the elevated plus maze, and mild cognitive impairment during the transfer task in the water maze. These analyses demonstrate that p300 +/− mice exhibit phenotypes that are reminiscent of neurological traits observed in RSTS patients, but their comparison with previous studies on CBP deficient strains also indicates that, in agreement with the most recent findings in human patients, the activity of p300 in cognition is likely less relevant or more susceptible to compensation than the activity of CBP.
Introduction
Rubinstein-Taybi syndrome (RSTS, OMIM #180849) is a complex autosomal-dominant disease characterized by mental impairment, growth retardation and characteristic skeletal abnormalities, such as apparent hypertelorism, prominent nose, malpositioned ears and broad thumbs and toes (Rubinstein and Taybi, 1963) . Petrij and colleagues (1995) discovered 14 years ago that about 40% of the individuals diagnosed with RSTS carried heterozygous mutations in CREBBP, the gene encoding for the CREB binding protein (CBP). Later studies have increased this number up to 60% of the individual diagnosed with this condition (Bentivegna et al., 2006) , and revealed that a small percentage (∼ 3%) of cases diagnosed as RSTS were caused by mutations of the gene EP300, which encodes for the co-activator p300 that is highly homologous to CBP (Bartholdi et al., 2007; Roelfsema et al., 2005; Zimmermann et al., 2007) .
CBP and p300 proteins function as co-factors for many transcription factors (Chan and La Thangue, 2001) including several transcription factors known to be regulated or induced by neuronal activity, such as CREB, c-Fos, c-Jun, or NF-κβ. In addition, both proteins have histone acetyltransferase (HAT) activity that targets the N-terminal unstructured tails of histones and may contribute to transcriptional activation by relaxing the structure of the nucleosomes (Ogryzko et al., 1996) . Their role in activity-dependent chromatin modification and gene expression may account for at least part of the cognitive and physiological alterations associated to mental retardation in RSTS patients.
Although the primary sequence of p300 and CBP are more than 70% similar and they have many common interaction partners, these two proteins have distinct cellular functions and cannot always replace one another (Kalkhoven, 2004) . The recent characterization of a number of mouse strains deficient in CBP activity has provided important new insight into the role of CBP in RSTS molecular etiology and opened new therapeutic avenues to treat this condition (Alarcon et al., 2004; Bourtchouladze et al., 2003; Korzus et al., 2004; Wood et al., 2006; Wood et al., 2005; reviewed by Barco, 2007) . In contrast, the role of p300 in cognition and behavior remains poorly explored, although it has been recently shown that conditional transgenic mice expressing an inhibitory truncated form of p300 had mild memory deficits (Oliveira et al., 2007) .
Here, we carried out a comprehensive analysis, including anatomical, behavioral, biochemical and gene profiling assays, of mice bearing a deleted p300 allele. Our results demonstrate skeletal abnormalities reminiscent of RSTS, mild motor and cognitive deficits and enhanced anxiety in the elevated plus maze, but unaltered levels of acetylated histones and negligible changes in gene expression except for p300 Neurobiology of Disease 37 (2010) 186-194 
